FDA Inspection 1093235 — Aspire Independent Review Board LLC
The FDA completed an inspection of Aspire Independent Review Board LLC on June 13, 2019 in Santee, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Santee, CA (United States)
Additional Details
IRB